Isaji Mako, Mune Tomoatsu, Takada Nobuki, Yamamoto Yoritsuna, Suwa Tetsuya, Morita Hiroyuki, Takeda Jun, White Perrin C
Department of Diabetes and Endocrinology, Gifu University School of Medicine, Yanagido, Gifu, Japan.
J Hypertens. 2005 Jun;23(6):1149-57. doi: 10.1097/01.hjh.0000170377.00591.7e.
Aldosterone has essential roles in regulating intravascular volume and blood pressure, and is suggested to influence cardiac structure. However, the association of polymorphisms in the aldosterone synthase gene (CYP11B2) with hypertension or cardiac hypertrophy remains controversial.
To evaluate the distribution of polymorphisms in the CYP11B2 gene and the possible associations between genotypes and blood pressure, urinary excretion of aldosterone or electrolytes and echocardiographic measurements, in a Japanese population.
We examined the association of two common diallelic polymorphisms within CYP11B2, one in the promoter -344T/C and the other an intron 2 gene conversion, with blood pressure, 24-h urinary excretion of aldosterone and electrolytes, and echocardiographic measurements, in a Japanese population. We confirmed significant linkage disequilibrium between these polymorphic loci and ethnic differences in frequency of the alleles. The -344C and -344T haplotypes apparently diverged before the intron conversion polymorphism was generated on the latter haplotype. Allele frequencies did not differ between 535 normotensive and 360 hypertensive individuals or between hypertensive individuals with higher and lower concentrations of renin. The only significant correlation was a positive correlation of left ventricular mass with 24-h urinary excretion of sodium, which occurred only in individuals with the -344CC genotype or the intron 2 conversion (-/-) genotype.
The -344CC or intron 2 conversion (-/-) genotype in CYP11B2 may be a risk factor for developing sodium-sensitive cardiac hypertrophy. Ethnic differences in the distribution of CYP11B2 genotypes combined with differences in salt intake might account for inconsistencies between previous reports.
醛固酮在调节血管内容量和血压方面起着重要作用,并且被认为会影响心脏结构。然而,醛固酮合酶基因(CYP11B2)多态性与高血压或心脏肥大之间的关联仍存在争议。
在日本人群中评估CYP11B2基因多态性的分布,以及基因型与血压、醛固酮或电解质的尿排泄量和超声心动图测量值之间的可能关联。
我们在日本人群中研究了CYP11B2内两个常见的双等位基因多态性的关联,一个位于启动子-344T/C,另一个是内含子2基因转换,与血压、醛固酮和电解质的24小时尿排泄量以及超声心动图测量值之间的关联。我们证实了这些多态性位点之间存在显著的连锁不平衡以及等位基因频率的种族差异。-344C和-344T单倍型显然在后者单倍型上产生内含子转换多态性之前就已经分化。535名血压正常者和360名高血压患者之间或肾素浓度较高和较低的高血压患者之间的等位基因频率没有差异。唯一显著的相关性是左心室质量与24小时尿钠排泄量呈正相关,这仅发生在具有-344CC基因型或内含子2转换(-/-)基因型的个体中。
CYP11B2基因中的-344CC或内含子2转换(-/-)基因型可能是发生钠敏感性心脏肥大的危险因素。CYP11B2基因型分布的种族差异与盐摄入量差异可能解释了先前报道之间的不一致。